Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Are all β-blockers the same? Nebivolol vasodilator properties and evidence for relevance in treatment of hypertension.

Literature DB >> 25440024

Are all β-blockers the same? Nebivolol vasodilator properties and evidence for relevance in treatment of hypertension.

Mehmet Kanbay¹, Baris Afsar.

Abstract

Entities: Chemical

Mesh：

Substances：

Year: 2014 PMID： 25440024 PMCID： PMC8031869 DOI： 10.1111/jch.12447

Source DB: PubMed Journal: J Clin Hypertens (Greenwich) ISSN： 1524-6175 Impact factor: 3.738

× No keyword cloud information.

23 in total

1. Different patterns of peripheral versus central blood pressure in hypertensive patients treated with β-blockers either with or without vasodilator properties or with angiotensin receptor blockers.

Authors: Jorge Polónia; Loide Barbosa; José Alberto Silva; Susana Bertoquini
Journal: Blood Press Monit Date: 2010-10 Impact factor: 1.444

Review 2. Beta-blockers in hypertension.

Authors: C Venkata S Ram
Journal: Am J Cardiol Date: 2010-11-02 Impact factor: 2.778

3. Lack of difference between nebivolol/hydrochlorothiazide and metoprolol/hydrochlorothiazide on aortic wave augmentation and central blood pressure.

Authors: Daan W Eeftinck Schattenkerk; Bas van den Bogaard; Marianne Cammenga; Berend E Westerhof; Erik S G Stroes; Bert-Jan H van den Born
Journal: J Hypertens Date: 2013-12 Impact factor: 4.844

Review 4. Nebivolol: a review of its clinical and pharmacological characteristics.

Authors: W Gielen; T J Cleophas; R Agrawal
Journal: Int J Clin Pharmacol Ther Date: 2006-08 Impact factor: 1.366

5. The effect of nebivolol versus metoprolol succinate extended release on asymmetric dimethylarginine in hypertension.

Authors: Ramprasad Kandavar; Yusuke Higashi; Wei Chen; Christopher Blackstock; Charlotte Vaughn; Sergiy Sukhanov; Gary E Sander; Louise E Roffidal; Patrice Delafontaine; Thomas D Giles
Journal: J Am Soc Hypertens Date: 2011-01-19

6. Central pressure more strongly relates to vascular disease and outcome than does brachial pressure: the Strong Heart Study.

Authors: Mary J Roman; Richard B Devereux; Jorge R Kizer; Elisa T Lee; James M Galloway; Tauqeer Ali; Jason G Umans; Barbara V Howard
Journal: Hypertension Date: 2007-05-07 Impact factor: 10.190

Are all β-blockers the same? Nebivolol vasodilator properties and evidence for relevance in treatment of hypertension.

1. Different patterns of peripheral versus central blood pressure in hypertensive patients treated with β-blockers either with or without vasodilator properties or with angiotensin receptor blockers.

Review 2. Beta-blockers in hypertension.

3. Lack of difference between nebivolol/hydrochlorothiazide and metoprolol/hydrochlorothiazide on aortic wave augmentation and central blood pressure.

Review 4. Nebivolol: a review of its clinical and pharmacological characteristics.

5. The effect of nebivolol versus metoprolol succinate extended release on asymmetric dimethylarginine in hypertension.

6. Central pressure more strongly relates to vascular disease and outcome than does brachial pressure: the Strong Heart Study.

7. Involvement of the beta3 adrenoceptor in nebivolol-induced vasorelaxation in the rat aorta.

8. High central pulse pressure is independently associated with adverse cardiovascular outcome the strong heart study.

9. Beta-blockers reduce aortic stiffness in hypertension but nebivolol, not atenolol, reduces wave reflection.

10. Effects of renin-angiotensin-aldosterone system inhibitors and beta-blockers on markers of arterial stiffness.

1. Gellan Gum-Based Hydrogel for the Transdermal Delivery of Nebivolol: Optimization and Evaluation.